Pfizer CEO Joins Host of Executives at Covid-19 Vaccine Makers in Big Stock Sale

The timing this week of Albert Bourla’s sale of about $5.6 million in company shares—on the same day it announced positive results from its Covid-19 vaccine—is drawing scrutiny from some investors

from WSJ.com: Markets https://ift.tt/3nhq1db
https://ift.tt/eA8V8J